Welcome to our dedicated page for Blue Owl Capital news (Ticker: OBDC), a resource for investors and traders seeking the latest updates and insights on Blue Owl Capital stock.
Blue Owl Capital Corporation reports developments for a specialty finance business development company focused on lending to U.S. middle-market companies. News commonly centers on quarterly financial results, GAAP and adjusted net investment income, net asset value, portfolio commitments, sales and repayments, non-accrual activity, dividends, liquidity and stock repurchase programs.
Coverage also includes OBDC's externally managed structure under Blue Owl Credit Advisors LLC and portfolio-company activity such as Wingspire Equipment Finance transactions. These updates reflect the company's direct-lending portfolio, BDC regulation under the Investment Company Act of 1940 and recurring capital-structure and governance matters.
Blue Owl Capital (NYSE: OBDC) will release its Q2 2024 financial results on August 7, 2024, post-market close.
OBDC has scheduled a webcast / conference call on August 8, 2024, at 10:00 a.m. ET to discuss the results.
Interested participants can access the call through OBDC's website or by dialing provided numbers.
For those unable to attend, a replay will be available on OBDC's website for one year and via dial-in for 14 days.
All participants are advised to connect 10-15 minutes before the call starts.
Wingspire Equipment Finance has extended $13 million in financing to a growing chain of over 50 fitness clubs, making it one of the top 20 largest health club operators in the U.S. The financing, structured as an operating lease, will support the acquisition of essential equipment for nine new locations. This move aims to expand the fitness company's nationwide presence and boost top-line revenue by increasing its membership base. Previously facing challenges in securing financing, the company now gains critical support from Wingspire to continue its growth trajectory.
Wingspire Equipment Finance has completed a $12 million equipment financing arrangement for a leading pharmaceutical services company. The CDMO, supported by private equity, specializes in drug development, manufacturing, and commercial packaging. This financial package includes a capital lease and sale-leaseback, aimed at acquiring new manufacturing and packaging technology. The financing helps optimize cash flow and enhance liquidity, supporting the company's growth. Jason Alves, Senior VP at Wingspire, emphasized the importance of this partnership in meeting the client’s financial goals and ensuring their operational success.
Blue Owl Capital reported a strong first quarter with net investment income per share of $0.47, exceeding dividends by 25%. The NAV per share increased to $15.47, the highest since inception. The company declared a first quarter supplemental dividend of $0.05 per share. The Board approved a 2024 Repurchase Program of up to $150 million. Investment income increased to $399.6 million, expenses rose to $211.6 million, and liquidity stood at $742.8 million in cash.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.